Synthesis and biological evaluation of NK1 antagonists derived from L-tryptophan. 1995

A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
Merck, Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, U.K.

The 3,5-bis(trifluoromethyl)benzyl ester of N-acetyl-L-tryptophan (3), which was derived from the screening lead N-ethyl-L-tryptophan benzyl ester, has been used as a starting point to identify high-affinity substance P receptor antagonists with improved in vivo activity. Altering the ester moiety to an amide or ether led to a substantial loss in binding affinity, but conversion to a ketone provided compounds with affinity comparable to the equivalent esters. A homochiral synthesis of the key intermediate amino ketone 15 was developed which allows its preparation on a large scale. From this intermediate a range of amine-containing acylamino derivatives were prepared with affinity optimized in the morpholinylbutyramide 161 which has an IC50 of 0.17 nM at the human NK1 receptor. In addition to improving affinity, the amino group also provided aqueous solubility for a number of these derivatives. When tested in vivo the quinuclidine derivative L-737,488 (16i) was found to be an orally active (ID50 = 1.8 mg/kg) inhibitor of substance P-induced dermal extravasation in the guinea pig.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010880 Piperidines A family of hexahydropyridines.
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D005119 Extravasation of Diagnostic and Therapeutic Materials The escape of diagnostic or therapeutic material from the vessel into which it is introduced into the surrounding tissue or body cavity. Extravasation of Contrast Media,Extravasation of Diagnostic, Therapeutic Materials,Contrast Media Extravasation
D005260 Female Females
D005289 Ferrets Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE. Domestic Polecat,Domestic Polecats,European Polecat,European Polecats,Ferret,Mustela putorius,Mustela putorius furo,Polecat, Domestic,Polecat, European,Polecats, Domestic,Polecats, European
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea

Related Publications

A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
August 1998, Bioorganic & medicinal chemistry letters,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
October 1997, Farmaco (Societa chimica italiana : 1989),
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
January 1994, Neuropeptides,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
December 2008, European journal of medicinal chemistry,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
July 2006, Bioorganic & medicinal chemistry,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
June 2019, European journal of medicinal chemistry,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
October 2000, Bioorganic & medicinal chemistry letters,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
January 1990, Peptides,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
August 1998, Bioorganic & medicinal chemistry,
A M MacLeod, and M A Cascieri, and K J Merchant, and S Sadowski, and S Hardwicke, and R T Lewis, and D E MacIntyre, and J M Metzger, and T M Fong, and S Shepheard
January 2006, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!